Grycerol 2-O-fucopyranoside

Details

Top
Internal ID c6269904-af4e-4d2f-a0da-c83675c2ca29
Taxonomy Organic oxygen compounds > Organooxygen compounds > Carbohydrates and carbohydrate conjugates > Glycosyl compounds > O-glycosyl compounds
IUPAC Name (2R,3S,4R,5S,6S)-2-(1,3-dihydroxypropan-2-yloxy)-6-methyloxane-3,4,5-triol
SMILES (Canonical) CC1C(C(C(C(O1)OC(CO)CO)O)O)O
SMILES (Isomeric) C[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)OC(CO)CO)O)O)O
InChI InChI=1S/C9H18O7/c1-4-6(12)7(13)8(14)9(15-4)16-5(2-10)3-11/h4-14H,2-3H2,1H3/t4-,6+,7+,8-,9-/m0/s1
InChI Key ZVTDSJFUFCKPJJ-VDTAYCBBSA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C9H18O7
Molecular Weight 238.23 g/mol
Exact Mass 238.10525291 g/mol
Topological Polar Surface Area (TPSA) 120.00 Ų
XlogP -2.90
Atomic LogP (AlogP) -2.82
H-Bond Acceptor 7
H-Bond Donor 5
Rotatable Bonds 4

Synonyms

Top
glycerol 2-O-alpha-l-fucopyranoside

2D Structure

Top
2D Structure of Grycerol 2-O-fucopyranoside

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption - 0.8941 89.41%
Caco-2 - 0.8357 83.57%
Blood Brain Barrier + 0.6750 67.50%
Human oral bioavailability - 0.6857 68.57%
Subcellular localzation Mitochondria 0.7662 76.62%
OATP2B1 inhibitior - 0.8572 85.72%
OATP1B1 inhibitior + 0.9451 94.51%
OATP1B3 inhibitior + 0.9521 95.21%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.8750 87.50%
BSEP inhibitior - 0.9621 96.21%
P-glycoprotein inhibitior - 0.9381 93.81%
P-glycoprotein substrate - 0.9519 95.19%
CYP3A4 substrate - 0.5755 57.55%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8487 84.87%
CYP3A4 inhibition - 0.9797 97.97%
CYP2C9 inhibition - 0.9716 97.16%
CYP2C19 inhibition - 0.9419 94.19%
CYP2D6 inhibition - 0.9659 96.59%
CYP1A2 inhibition - 0.9562 95.62%
CYP2C8 inhibition - 0.9551 95.51%
CYP inhibitory promiscuity - 0.9424 94.24%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.9600 96.00%
Carcinogenicity (trinary) Non-required 0.6737 67.37%
Eye corrosion - 0.9852 98.52%
Eye irritation - 0.9539 95.39%
Skin irritation - 0.8663 86.63%
Skin corrosion - 0.9647 96.47%
Ames mutagenesis - 0.5854 58.54%
Human Ether-a-go-go-Related Gene inhibition - 0.6518 65.18%
Micronuclear - 0.8341 83.41%
Hepatotoxicity - 0.6822 68.22%
skin sensitisation - 0.9307 93.07%
Respiratory toxicity - 0.6444 64.44%
Reproductive toxicity - 0.7778 77.78%
Mitochondrial toxicity - 0.8000 80.00%
Nephrotoxicity - 0.6643 66.43%
Acute Oral Toxicity (c) IV 0.5384 53.84%
Estrogen receptor binding - 0.7851 78.51%
Androgen receptor binding - 0.8616 86.16%
Thyroid receptor binding + 0.6165 61.65%
Glucocorticoid receptor binding - 0.5092 50.92%
Aromatase binding - 0.5804 58.04%
PPAR gamma - 0.6691 66.91%
Honey bee toxicity - 0.8595 85.95%
Biodegradation - 0.5500 55.00%
Crustacea aquatic toxicity - 0.8900 89.00%
Fish aquatic toxicity - 0.9305 93.05%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 94.20% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 86.84% 91.11%
CHEMBL3714130 P46095 G-protein coupled receptor 6 86.22% 97.36%
CHEMBL2581 P07339 Cathepsin D 84.52% 98.95%
CHEMBL226 P30542 Adenosine A1 receptor 83.19% 95.93%
CHEMBL3060 Q9Y345 Glycine transporter 2 82.65% 99.17%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 81.94% 95.89%
CHEMBL3401 O75469 Pregnane X receptor 81.80% 94.73%

Cross-Links

Top
PubChem 101159096
NPASS NPC252587
LOTUS LTS0077817
wikiData Q105384588